COVID-19 convalescent plasma product: Harvesting plasma from single unit whole blood, a cost effective alternative to plasmapheresis
The COVID-19 pandemic has affected people from almost all parts of the world. There is no specific pharmaceutical drug available. So also, there is no vaccine developed as yet. In the circumstance, the passive immunity imparted by the preformed antibody in the plasma from the convalescing patient co...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Global Journal of Transfusion Medicine |
Subjects: | |
Online Access: | http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2020;volume=5;issue=2;spage=209;epage=211;aulast=Joshi |